^Yamamoto-Hino M, Sugiyama T, Hikichi K, et al. (1994). "Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors". Recept. Channels. 2 (1): 9–22.
PMID8081734.
Further reading
Jardín I, Lápez JJ, Salido GM, Rosado JA (2008). "Functional relevance of the de novo coupling between hTRPC1 and type II IP3 receptor in store-operated Ca2+ entry in human platelets". Cell. Signal. 20 (4): 737–47.
doi:
10.1016/j.cellsig.2007.12.010.
PMID18249094.
van Es MA, Van Vught PW, Blauw HM, et al. (2007). "ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study". Lancet Neurology. 6 (10): 869–77.
doi:
10.1016/S1474-4422(07)70222-3.
PMID17827064.
S2CID12953367.
Miyachi K, Iwai M, Asada K, et al. (2007). "Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases". Mod Rheumatol. 17 (2): 137–43.
doi:
10.1007/s10165-006-0555-6.
PMID17437169.
S2CID36516047.
^Yamamoto-Hino M, Sugiyama T, Hikichi K, et al. (1994). "Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors". Recept. Channels. 2 (1): 9–22.
PMID8081734.
Further reading
Jardín I, Lápez JJ, Salido GM, Rosado JA (2008). "Functional relevance of the de novo coupling between hTRPC1 and type II IP3 receptor in store-operated Ca2+ entry in human platelets". Cell. Signal. 20 (4): 737–47.
doi:
10.1016/j.cellsig.2007.12.010.
PMID18249094.
van Es MA, Van Vught PW, Blauw HM, et al. (2007). "ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study". Lancet Neurology. 6 (10): 869–77.
doi:
10.1016/S1474-4422(07)70222-3.
PMID17827064.
S2CID12953367.
Miyachi K, Iwai M, Asada K, et al. (2007). "Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjögren's syndrome and other systemic rheumatic diseases". Mod Rheumatol. 17 (2): 137–43.
doi:
10.1007/s10165-006-0555-6.
PMID17437169.
S2CID36516047.